与拒绝血液输血相关的因素,在急性黄油中毒患者中
Minghao Zhang1,2, Shunzhong Zhao2,3, Mingji Sun1
1Department of Internal Medicine, The 63710 Force Hospital of Chinese People's Liberation Army, Xinzhou, China.
概括
老年患者和有精神疾病史的患者更有可能拒绝对帕拉克瓦特中毒的血液输血 (HP). 这种拒绝与帕奎特中毒病例中死亡率较高有关.
科学领域:
- 毒理学 毒理学 毒理学
- 公共卫生 公共卫生
- 临床医学 临床医学
背景情况:
- 帕拉克瓦特中毒是一个严重的公共卫生问题,治疗选择有限.
- 血 perfusion (HP) 是一种排毒方法,在一些国家用于急性水中毒.
- 患者拒绝推的HP治疗是注意到的,但不太了解.
研究的目的:
- 为了调查与拒绝血液输血 (HP) 相关的因素,在急性黄油中毒的患者.
- 为了确定帕奎特中毒中HP拒绝的预测因子.
主要方法:
- 在中国西安,对358名急性帕拉克瓦特中毒患者进行了回顾性分析.
- 后勤回归模型用于识别HP拒绝的独立风险因素.
- 分析的结果包括死亡率,年龄,性别,教育,症状和实验室发现.
主要成果:
- 拒绝HP的患者年龄较大,精神障碍,器官衰竭和机械呼吸率较高.
- 拒绝HP与明显更高的死亡率有关 (20.3%对10.9%).
- 拒绝HP的独立预测因素是晚年 (OR 1.76) 和精神疾病史 (OR 2.81).
结论:
- 老年患者和有精神障碍病史的患者独立地与拒绝对帕拉克瓦特中毒的输血有关.
- 了解这些因素对于改善治疗坚持和帕拉克瓦特中毒结果至关重要.
- 进一步的研究可能会探索有针对性的干预措施,以解决患者对HP的担忧.
相关概念视频
Anticholinesterase Agents: Poisoning and Treatment
813
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
813
Prevention of Further Absorption of Poison
801
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
801
Enhanced Elimination of Poison
489
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
489
Acute Respiratory Failure-II
186
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
186
Acute Respiratory Failure-III
163
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
163
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
104
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
104


